on July 26, 2004
Published online before print July 26, 2004, doi: 10.1161/01.CIR.0000138103.91187.E3
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 4, 2003
From the Division of Vascular Surgery, Department of Surgical Sciences and Intensive Care (G.M.B., A.F., G.D., P.M.) and Section of Statistics, Department of Clinical Medicine, Prevention and Biotechnologies (S.G., M.G.V.), University of Milano-Bicocca, Milan, Italy; Bassini/S. Gerardo Teaching Hospital, Milan, Italy (G.M.B., A.F., G.D., P.M.); Arizona Heart Institute and Foundation, Phoenix (E.B.D.); Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus (A.N.N.); Department of Academic Vascular Surgery, Imperial College, London, UK (M.G.); Vascular Surgical Service, Klinikum Nurnberg Sud, Nurnberg, Germany (D.R.); and Wishaw General Hospital, Wishaw, Scotland (D.B.R.). * To whom correspondence should be addressed. E-mail: giorgio.biasi{at}unimib.it.
Background--Carotid artery stenting (CAS) has recently emerged as a potential alternative to carotid endarterectomy. Cerebral embolization is the most devastating complication of CAS, and the echogenicity of carotid plaque has been indicated as one of the risk factors involved. This is the first study to analyze the role of a computer-assisted highly reproducible index of echogenicity, namely the gray-scale median (GSM), on the risk of stroke during CAS. Methods and Results--The Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) registry included 418 cases of CAS collected from 11 international centers. An echographic evaluation of carotid plaque with GSM measurement was made preprocedurally. The onset of neurological deficits during the procedure and the postprocedural period was recorded. The overall rate of neurological complications was 3.6%: minor strokes, 2.2%, and major stroke, 1.4%. There were 11 of 155 strokes (7.1%) in patients with GSM Conclusions--Carotid plaque echolucency, as measured by GSM
Revised on March 1, 2004
Accepted on March 17, 2004
Carotid Plaque Echolucency Increases the Risk of Stroke in Carotid Stenting. The Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) Study
Giorgio M. Biasi MD, FRCS*,
25 and 4 of 263 (1.5%) in patients with GSM >25 (P=0.005). Patients with severe stenosis (
85%) had a higher rate of stroke (P=0.03). The effectiveness of brain protection devices was confirmed in those with GSM >25 (P=0.01) but not in those with GSM 25. Multivariate analysis revealed that GSM (OR, 7.11; P=0.002) and rate of stenosis (OR, 5.76; P=0.010) are independent predictors of stroke.25, increases the risk of stroke in CAS. The inclusion of echolucency measured as GSM in the planning of any endovascular procedure of carotid lesions allows stratification of patients at different risks of complications in CAS.
Key words: carotid arteries • plaque • stents • stroke • ultrasonics
This article has been cited by other articles:
 |
|
 |
|
  M. Skjelland, K. Krohg-Sorensen, B. Tennoe, S. J. Bakke, R. Brucher, and D. Russell Cerebral Microemboli and Brain Injury During Carotid Artery Endarterectomy and Stenting Stroke, January 1, 2009; 40(1): 230 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Chaer and M. S. Makaroun Current Indications for Carotid Angioplasty and Stenting Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2008; 20(3): 239 - 244. [Abstract] [PDF]
|
|
|
|
|
|
F. Verzini, P. De Rango, G. Parlani, G. Panuccio, and P. Cao Carotid Artery Stenting: Technical Issues and Role of Operators' Experience Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2008; 20(3): 247 - 257. [Abstract] [PDF]
|
|
|
|
|
|
M. Bosiers, K. Deloose, J. Verbist, and P. Peeters The Impact of Embolic Protection Device and Stent Design on the Outcome of CAS Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2008; 20(3): 272 - 279. [Abstract] [PDF]
|
|
|
|
|
|
R. Kelso and D. G. Clair Flow Reversal for Cerebral Protection in Carotid Artery Stenting: A Review Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2008; 20(3): 282 - 290. [Abstract] [PDF]
|
|
|
|
 |
|
 R. M. Kwee, R. J. van Oostenbrugge, L. Hofstra, G. J. Teule, J.M.A. van Engelshoven, W. H. Mess, and M. E. Kooi Identifying vulnerable carotid plaques by noninvasive imaging Neurology, June 10, 2008; 70(24_Part_2): 2401 - 2409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wintermark, S.S. Jawadi, J.H. Rapp, T. Tihan, E. Tong, D.V. Glidden, S. Abedin, S. Schaeffer, G. Acevedo-Bolton, B. Boudignon, et al. High-Resolution CT Imaging of Carotid Artery Atherosclerotic Plaques AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 875 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yoshida, O. Narumi, M. Chin, K. Inoue, T. Tabuchi, K. Oda, M. Nagayama, N. Egawa, M. Hojo, Y. Goto, et al. Characterization of Carotid Atherosclerosis and Detection of Soft Plaque with Use of Black-Blood MR Imaging AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 868 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Martin, D. Gunnell, E. Whitley, A. Nicolaides, M. Griffin, N. Georgiou, G. Davey Smith, S. Ebrahim, and J. M. P. Holly Associations of Insulin-Like Growth Factor (IGF)-I, IGF-II, IGF Binding Protein (IGFBP)-2 and IGFBP-3 with Ultrasound Measures of Atherosclerosis and Plaque Stability in an Older Adult Population J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1331 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rundek, H. Arif, B. Boden-Albala, M. S. Elkind, M. C. Paik, and R. L. Sacco Carotid plaque, a subclinical precursor of vascular events: The Northern Manhattan Study Neurology, April 1, 2008; 70(14): 1200 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Eskandari Preventable Complications of Carotid Stenting Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2008; 20(1): 17 - 25. [Abstract] [PDF]
|
|
|
|
|
|
W. E. Hellings, F. L. Moll, J.-P. P.M. de Vries, P. de Bruin, D. P.V. de Kleijn, and G. Pasterkamp Histological Characterization of Restenotic Carotid Plaques in Relation to Recurrence Interval and Clinical Presentation: A Cohort Study Stroke, March 1, 2008; 39(3): 1029 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Veeraswamy, B. G. Rubin, L. A. Sanchez, M. A. Curi, P. J Geraghty, J. C. Parodi, and G. A. Sicard Complications of Carotid Artery Stenting Are Largely Preventable: A Retrospective Error Analysis Perspectives in Vascular Surgery and Endovascular Therapy, December 1, 2007; 19(4): 403 - 408. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Mahmud, J. J. Cavendish, and A. Salami Current Treatment of Peripheral Arterial Disease: Role of Percutaneous Interventional Therapies J. Am. Coll. Cardiol., August 7, 2007; 50(6): 473 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Maynar, S. Baldi, R. Rostagno, T. Zander, M. Rabellino, R. Llorens, J. Alvarez, and F. Barajas Carotid Stenting without Use of Balloon Angioplasty and Distal Protection Devices: Preliminary Experience in 100 Cases AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1378 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Froio and G. M. Biasi Carotid Plaque Echolucency Predicts the Risk of Stroke in Carotid Stenting According to the Type of Brain Protection Device and the Learning Curve Stroke, August 1, 2007; 38(8): e67 - e67. [Full Text] [PDF]
|
|
|
|
|
|
M. Reiter and M. Schillinger Response to the Letter by Froio and Biasi Stroke, August 1, 2007; 38(8): e68 - e68. [Full Text] [PDF]
|
|
|
|
 |
|
 K. I. Paraskevas, D. P. Mikhailidis, and C. D. Liapis Internal Carotid Artery Occlusion: Association With Atherosclerotic Disease in Other Arterial Beds and Vascular Risk Factors Angiology, June 1, 2007; 58(3): 329 - 335. [Abstract] [PDF]
|
|
|
|
 |
|
 E. R. Bates, C. J. D. Babb, D. E. Casey, C. U. Cates, G. R. Duckwiler, T. E. Feldman, W. A. Gray, K. Ouriel, E. D. Peterson, K. Rosenfield, et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting) Vascular Medicine, February 1, 2007; 12(1): 35 - 83. [PDF]
|
|
|
|
|
|
B. G. Rubin Impact of Plaque Characterization on Carotid Interventions Perspectives in Vascular Surgery and Endovascular Therapy, December 1, 2006; 18(4): 312 - 315. [Abstract] [PDF]
|
|
|
|
|
|
M. Reiter, R. A. Bucek, I. Effenberger, J. Boltuch, W. Lang, R. Ahmadi, E. Minar, and M. Schillinger Plaque Echolucency Is Not Associated With the Risk of Stroke in Carotid Stenting Stroke, September 1, 2006; 37(9): 2378 - 2380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Asakura, K. Kawaguchi, H. Sakaida, N. Toma, S. Matsushima, K. Kuraishi, H. Tanemura, Y. Miura, M. Maeda, and W. Taki Diffusion-weighted MR imaging in carotid angioplasty and stenting with protection by the reversed carotid arterial flow. AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 753 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. I. Bluth, J. A. Vos, and R. G. A. Ackerstaff Value of US in Selecting Patients for Carotid Angioplasty and Stent Placement * Drs Vos and Ackerstaff respond: Radiology, October 1, 2005; 237(1): 374 - 375. [Full Text] [PDF]
|
|
|
|
|
|
K. I. Paraskevas, S. S. Daskalopoulou, M. E. Daskalopoulos, and C. D. Liapis Secondary Prevention of Ischemic Cerebrovascular Disease. What Is the Evidence? Angiology, September 1, 2005; 56(5): 539 - 552. [Abstract] [PDF]
|
|
|
|
|
|
D. Pelz, T. Andersson, P. Lylyk, M. Negoro, and M. Soderman Stroke Review: Advances in Interventional Neuroradiology 2004 Stroke, February 1, 2005; 36(2): 211 - 214. [Full Text] [PDF]
|
|